0001400118-13-000001.txt : 20130627 0001400118-13-000001.hdr.sgml : 20130627 20130626213503 ACCESSION NUMBER: 0001400118-13-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130627 DATE AS OF CHANGE: 20130626 EFFECTIVENESS DATE: 20130627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 3-V Biosciences, Inc. CENTRAL INDEX KEY: 0001400118 IRS NUMBER: 205991472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-198677 FILM NUMBER: 13935811 BUSINESS ADDRESS: STREET 1: 1050 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 320-1760 MAIL ADDRESS: STREET 1: 1050 HAMILTON COURT CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0706 D LIVE 0001400118 3-V Biosciences, Inc. 1050 HAMILTON COURT MENLO PARK CA CALIFORNIA 94025 (650) 320-1760 DELAWARE None None Corporation true Merdad Parsey c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Executive Officer Director Beth Seidenberg c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director Ari Helenius c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director Gordon Ringold c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director Robert Garland c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director David Mott c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director James Young c/o 3-V Biosciences, Inc. 1050 Hamilton Court Menlo Park CA CALIFORNIA 94025 Director Biotechnology Decline to Disclose 06 false 2013-06-14 true true true true false 0 20376959 7504260 12872699 The total offering amount includes the purchase price of the Series C Preferred Stock, the purchase price of the Common Stock Warrants and the potential proceeds from the exercise of the Common Stock Warrants. false 2 0 0 0 The proceeds will be used for working capital. false 3-V Biosciences, Inc. /s/ Merdad Parsey, MD, Ph.D Merdad Parsey, MD, Ph.D Chief Executive Officer 2013-06-26